vs

Side-by-side financial comparison of P3 Health Partners Inc. (PIII) and Tyler Technologies (TYL). Click either name above to swap in a different company.

Tyler Technologies is the larger business by last-quarter revenue ($575.2M vs $384.8M, roughly 1.5× P3 Health Partners Inc.). Tyler Technologies runs the higher net margin — 11.4% vs -19.6%, a 31.0% gap on every dollar of revenue. On growth, Tyler Technologies posted the faster year-over-year revenue change (6.3% vs 3.8%). Over the past eight quarters, Tyler Technologies's revenue compounded faster (6.0% CAGR vs -0.5%).

P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.

Tyler Technologies, Inc. is an American technology company based in Plano, Texas, that provides proprietary software to the U.S. public sector. Tyler Technologies has offices in 17 states and one in Toronto, Ontario, Canada.

PIII vs TYL — Head-to-Head

Bigger by revenue
TYL
TYL
1.5× larger
TYL
$575.2M
$384.8M
PIII
Growing faster (revenue YoY)
TYL
TYL
+2.5% gap
TYL
6.3%
3.8%
PIII
Higher net margin
TYL
TYL
31.0% more per $
TYL
11.4%
-19.6%
PIII
Faster 2-yr revenue CAGR
TYL
TYL
Annualised
TYL
6.0%
-0.5%
PIII

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PIII
PIII
TYL
TYL
Revenue
$384.8M
$575.2M
Net Profit
$-75.5M
$65.5M
Gross Margin
45.5%
Operating Margin
-40.0%
13.0%
Net Margin
-19.6%
11.4%
Revenue YoY
3.8%
6.3%
Net Profit YoY
-28.8%
0.5%
EPS (diluted)
$-23.08
$1.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PIII
PIII
TYL
TYL
Q4 25
$384.8M
$575.2M
Q3 25
$345.3M
$595.9M
Q2 25
$355.8M
$596.1M
Q1 25
$373.2M
$565.2M
Q4 24
$370.7M
$541.1M
Q3 24
$362.1M
$543.3M
Q2 24
$379.2M
$541.0M
Q1 24
$388.5M
$512.4M
Net Profit
PIII
PIII
TYL
TYL
Q4 25
$-75.5M
$65.5M
Q3 25
$-31.6M
$84.4M
Q2 25
$-20.4M
$84.6M
Q1 25
$-20.5M
$81.1M
Q4 24
$-58.6M
$65.2M
Q3 24
$-46.5M
$75.9M
Q2 24
$-12.0M
$67.7M
Q1 24
$-18.7M
$54.2M
Gross Margin
PIII
PIII
TYL
TYL
Q4 25
45.5%
Q3 25
47.2%
Q2 25
45.8%
Q1 25
47.3%
Q4 24
43.8%
Q3 24
43.7%
Q2 24
44.0%
Q1 24
43.7%
Operating Margin
PIII
PIII
TYL
TYL
Q4 25
-40.0%
13.0%
Q3 25
-12.8%
16.4%
Q2 25
-9.6%
16.0%
Q1 25
-10.2%
15.8%
Q4 24
-37.4%
13.2%
Q3 24
-29.5%
15.2%
Q2 24
-8.3%
14.4%
Q1 24
-11.3%
13.1%
Net Margin
PIII
PIII
TYL
TYL
Q4 25
-19.6%
11.4%
Q3 25
-9.1%
14.2%
Q2 25
-5.7%
14.2%
Q1 25
-5.5%
14.3%
Q4 24
-15.8%
12.1%
Q3 24
-12.8%
14.0%
Q2 24
-3.2%
12.5%
Q1 24
-4.8%
10.6%
EPS (diluted)
PIII
PIII
TYL
TYL
Q4 25
$-23.08
$1.50
Q3 25
$-9.67
$1.93
Q2 25
$-6.23
$1.93
Q1 25
$-6.28
$1.84
Q4 24
$-23.13
$1.48
Q3 24
$-15.70
$1.74
Q2 24
$-7.37
$1.57
Q1 24
$-7.86
$1.26

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PIII
PIII
TYL
TYL
Cash + ST InvestmentsLiquidity on hand
$25.0M
$1.1B
Total DebtLower is stronger
$228.4M
$599.7M
Stockholders' EquityBook value
$-155.2M
$3.7B
Total Assets
$656.6M
$5.6B
Debt / EquityLower = less leverage
0.16×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PIII
PIII
TYL
TYL
Q4 25
$25.0M
$1.1B
Q3 25
$37.7M
$950.8M
Q2 25
$38.6M
$892.3M
Q1 25
$40.1M
$807.4M
Q4 24
$38.8M
$768.0M
Q3 24
$63.0M
$544.3M
Q2 24
$73.1M
$258.0M
Q1 24
$27.3M
$196.9M
Total Debt
PIII
PIII
TYL
TYL
Q4 25
$228.4M
$599.7M
Q3 25
$252.8M
$599.2M
Q2 25
$182.0M
$598.8M
Q1 25
$171.1M
$598.4M
Q4 24
$108.9M
$597.9M
Q3 24
$133.2M
$597.5M
Q2 24
$133.1M
$597.1M
Q1 24
$118.1M
$596.6M
Stockholders' Equity
PIII
PIII
TYL
TYL
Q4 25
$-155.2M
$3.7B
Q3 25
$-18.7M
$3.6B
Q2 25
$44.5M
$3.6B
Q1 25
$63.3M
$3.5B
Q4 24
$75.9M
$3.4B
Q3 24
$120.5M
$3.3B
Q2 24
$166.8M
$3.1B
Q1 24
$146.6M
$3.0B
Total Assets
PIII
PIII
TYL
TYL
Q4 25
$656.6M
$5.6B
Q3 25
$683.6M
$5.5B
Q2 25
$731.6M
$5.4B
Q1 25
$783.9M
$5.2B
Q4 24
$783.4M
$5.2B
Q3 24
$833.3M
$5.0B
Q2 24
$892.8M
$4.8B
Q1 24
$855.9M
$4.6B
Debt / Equity
PIII
PIII
TYL
TYL
Q4 25
0.16×
Q3 25
0.17×
Q2 25
4.09×
0.16×
Q1 25
2.71×
0.17×
Q4 24
1.43×
0.18×
Q3 24
1.11×
0.18×
Q2 24
0.80×
0.19×
Q1 24
0.81×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PIII
PIII
TYL
TYL
Operating Cash FlowLast quarter
$-25.7M
$243.9M
Free Cash FlowOCF − Capex
$239.6M
FCF MarginFCF / Revenue
41.7%
Capex IntensityCapex / Revenue
0.8%
Cash ConversionOCF / Net Profit
3.72×
TTM Free Cash FlowTrailing 4 quarters
$637.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PIII
PIII
TYL
TYL
Q4 25
$-25.7M
$243.9M
Q3 25
$-15.4M
$255.2M
Q2 25
$-16.6M
$98.3M
Q1 25
$-33.5M
$56.2M
Q4 24
$-57.2M
$224.8M
Q3 24
$-22.6M
$263.7M
Q2 24
$-10.2M
$64.3M
Q1 24
$-20.0M
$71.8M
Free Cash Flow
PIII
PIII
TYL
TYL
Q4 25
$239.6M
Q3 25
$251.3M
Q2 25
$92.8M
Q1 25
$53.8M
Q4 24
$221.0M
Q3 24
$260.8M
Q2 24
$57.7M
Q1 24
$64.6M
FCF Margin
PIII
PIII
TYL
TYL
Q4 25
41.7%
Q3 25
42.2%
Q2 25
15.6%
Q1 25
9.5%
Q4 24
40.8%
Q3 24
48.0%
Q2 24
10.7%
Q1 24
12.6%
Capex Intensity
PIII
PIII
TYL
TYL
Q4 25
0.8%
Q3 25
0.7%
Q2 25
0.9%
Q1 25
0.4%
Q4 24
0.0%
0.7%
Q3 24
0.0%
0.5%
Q2 24
0.0%
1.2%
Q1 24
0.0%
1.4%
Cash Conversion
PIII
PIII
TYL
TYL
Q4 25
3.72×
Q3 25
3.02×
Q2 25
1.16×
Q1 25
0.69×
Q4 24
3.45×
Q3 24
3.47×
Q2 24
0.95×
Q1 24
1.33×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PIII
PIII

Capitated Revenue$366.2M95%
Health Care Patient Service$18.6M5%
Health Care Care Coordination Management Fees$2.7M1%

TYL
TYL

Saas Arrangements$186.1M32%
Platform Technologies Segment$143.3M25%
Maintenance$109.4M19%
Professional Services$55.3M10%
Nonrecurring Revenue$51.3M9%
Other$21.4M4%
Hardware And Other$8.4M1%

Related Comparisons